- Home
- FLGC vs PSTV Comparison
FLGC vs PSTV Comparison
Compare FLGC & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLGC
- PSTV
- Stock Information
- Founded
- FLGC 2019
- PSTV 1996
- Country
- FLGC United States
- PSTV United States
- Employees
- FLGC N/A
- PSTV N/A
- Industry
- FLGC Biotechnology: Pharmaceutical Preparations
- PSTV Medical/Dental Instruments
- Sector
- FLGC Health Care
- PSTV Health Care
- Exchange
- FLGC Nasdaq
- PSTV Nasdaq
- Market Cap
- FLGC 15.9M
- PSTV 17.0M
- IPO Year
- FLGC 2021
- PSTV N/A
- Fundamental
- Price
- FLGC $22.50
- PSTV $0.49
- Analyst Decision
- FLGC Strong Buy
- PSTV Strong Buy
- Analyst Count
- FLGC 1
- PSTV 4
- Target Price
- FLGC $156.00
- PSTV $7.88
- AVG Volume (30 Days)
- FLGC 15.8K
- PSTV 8.2M
- Earning Date
- FLGC 08-01-2025
- PSTV 08-14-2025
- Dividend Yield
- FLGC N/A
- PSTV N/A
- EPS Growth
- FLGC N/A
- PSTV N/A
- EPS
- FLGC N/A
- PSTV N/A
- Revenue
- FLGC $52,373,000.00
- PSTV $5,317,000.00
- Revenue This Year
- FLGC N/A
- PSTV $2.95
- Revenue Next Year
- FLGC $10.22
- PSTV $7.89
- P/E Ratio
- FLGC N/A
- PSTV N/A
- Revenue Growth
- FLGC N/A
- PSTV N/A
- 52 Week Low
- FLGC $15.15
- PSTV $0.16
- 52 Week High
- FLGC $82.29
- PSTV $2.31
- Technical
- Relative Strength Index (RSI)
- FLGC 52.11
- PSTV 48.30
- Support Level
- FLGC $21.70
- PSTV $0.39
- Resistance Level
- FLGC $22.95
- PSTV $0.54
- Average True Range (ATR)
- FLGC 1.63
- PSTV 0.05
- MACD
- FLGC 0.31
- PSTV -0.01
- Stochastic Oscillator
- FLGC 64.03
- PSTV 50.70
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).